Technical Analysis for ABCL - AbCellera Biologics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.67 | -1.48% | -0.04 |
ABCL closed down 1.48 percent on Wednesday, November 20, 2024, on 81 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Crossed Above 50 DMA | Bullish | -1.48% | |
| Calm After Storm | Range Contraction | -1.48% | |
| NR7 | Range Contraction | -1.48% | |
| NR7-2 | Range Contraction | -1.48% | |
| 50 DMA Resistance | Bearish | 0.75% | |
| Calm After Storm | Range Contraction | 0.75% | |
| NR7 | Range Contraction | 0.75% |
| Alert | Time |
|---|---|
| Fell Below 50 DMA | about 22 hours ago |
| Down 1% | about 22 hours ago |
| 50 DMA Resistance | 1 day ago |
| Possible NR7 | 1 day ago |
| Possible Inside Day | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Health Sciences Pharmacy Antibodies Medication Pharmacology Drug Development Pharmaceutical Sciences
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Health Sciences Pharmacy Antibodies Medication Pharmacology Drug Development Pharmaceutical Sciences
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.05 |
| 52 Week Low | 2.335 |
| Average Volume | 2,111,681 |
| 200-Day Moving Average | 3.46 |
| 50-Day Moving Average | 2.68 |
| 20-Day Moving Average | 2.78 |
| 10-Day Moving Average | 2.79 |
| Average True Range | 0.17 |
| RSI (14) | 46.81 |
| ADX | 13.11 |
| +DI | 19.75 |
| -DI | 20.74 |
| Chandelier Exit (Long, 3 ATRs) | 2.67 |
| Chandelier Exit (Short, 3 ATRs) | 3.01 |
| Upper Bollinger Bands | 3.03 |
| Lower Bollinger Band | 2.54 |
| Percent B (%b) | 0.27 |
| BandWidth | 17.48 |
| MACD Line | 0.01 |
| MACD Signal Line | 0.03 |
| MACD Histogram | -0.0261 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.82 | ||||
| Resistance 3 (R3) | 2.82 | 2.77 | 2.80 | ||
| Resistance 2 (R2) | 2.77 | 2.73 | 2.77 | 2.79 | |
| Resistance 1 (R1) | 2.72 | 2.71 | 2.70 | 2.72 | 2.78 |
| Pivot Point | 2.67 | 2.67 | 2.66 | 2.67 | 2.67 |
| Support 1 (S1) | 2.62 | 2.63 | 2.60 | 2.62 | 2.56 |
| Support 2 (S2) | 2.57 | 2.61 | 2.57 | 2.55 | |
| Support 3 (S3) | 2.52 | 2.57 | 2.55 | ||
| Support 4 (S4) | 2.52 |
